The prospect of a CR looms over this stock like a shadow. I'll never understand why they didn't raise earlier at say 30 cents. The problem they have now is they can't just take a large investor because the MC is too low and they'd have to sell too large a chunk, which would require SH approval. I thought ODD would be the required catalyst but it was lost in the turmoil of board and management changes. We need a spur. Could the SP driver be the return of Thurn?
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-135
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |